Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion description "[We tested the hypothesis that expression of Flt3L (human soluble FMS-like tyrosine kinase 3 ligand) and TK (herpes simplex virus type 1-thymidine kinase) within brain gliomas would mediate regression of the primary, treated tumor mass and a secondary, untreated tumor growing at a distant site from the primary tumor and the site of therapeutic vector injection.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion evidence source_evidence_literature NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion SIO_000772 18079358 NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion wasDerivedFrom befree-20150227 NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_assertion wasGeneratedBy ECO_0000203 NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP408304.RA43pH00s6CpWlWtOd3x073lwinK1UAI2KrfR6P4Lp-Uk130_provenance.